An early Canadian gene therapy study for Fabry disease has shown both clinical and economic benefits.

Researchers at the Vitalité Health Network are building the first province-wide genetic database in New Brunswick, aiming to improve early screening for inherited disorders like cystic fibrosis, sickle cell anemia, and Huntington’s disease.

When two siblings at the Stollery Children’s Hospital showed signs of a rare genetic disorder, the Translational Genomics Hub at the University of Alberta uncovered a novel gene variant that provided their family with a long-sought diagnosis.

A new $800K partnership between SickKids and CHU Sainte-Justine is accelerating access to customizable treatments for children with rare genetic conditions. The ASO Connect project aims to identify eligible patients and design RNA-based therapies (ASOs) to improve outcomes through personalized care.

Brain Canada has awarded a 2024 Platform Support Grant of $553,660 to Dr. Lawrence Korngut and the University of Calgary to expand the Canadian Neuromuscular Disease Registry (CNDR) into a cutting-edge, multi-modal open science platform.